Skip to content
TrialScanner

NCT05583344

Phase 2b Study of GSK4532990 in Adults With NASH

Phase 2CompletedGSKLead

Registry record

Lead sponsor
GlaxoSmithKline
Conditions
Nonalcoholic Fatty Liver Disease; Non-alcoholic Fatty Liver Disease
Primary completion
Jan 31, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05583344 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

2 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05583344: Phase 2b Study of GSK4532990... | TrialScanner